IE 11 is not supported. For an optimal experience visit our site on another browser.

Once free, treatment for a rare disease now costs $375K a year


"This was not good medicine, this was good lawyering," the mother of a patient dependent upon the drug tells NBC News. "They found a loophole and they took advantage of it." More on the accusations that a drug company is exploiting the law meant to encourage drug development for rare diseases on tonight's broadcast.